{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:45:58Z","timestamp":1762098358928},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.4065\/83.7.758","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:31:26Z","timestamp":1232760686000},"page":"758-764","source":"Crossref","is-referenced-by-count":67,"title":["Simvastatin vs Therapeutic Lifestyle Changes and Supplements: Randomized Primary Prevention Trial"],"prefix":"10.4065","volume":"83","author":[{"given":"David J.","family":"Becker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram Y.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patti B.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Yorko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Jerold","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayyar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9326","key":"10.4065\/83.7.758_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"issue":"25","key":"10.4065\/83.7.758_bib2","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/CIRCULATIONAHA.106.624890","article-title":"Risks associated with statin therapy: a systematic overview of randomized clinical trials","volume":"114","author":"Kashani","year":"2006","journal-title":"Circulation"},{"issue":"18","key":"10.4065\/83.7.758_bib3","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.279.18.1458","article-title":"Persistence of use of lipid-lowering medications: a cross-national study","volume":"279","author":"Avorn","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"10.4065\/83.7.758_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5694\/j.1326-5377.1996.tb94138.x","article-title":"Apparent discontinuation rates in patients prescribed lipid-lowering drugs","volume":"164","author":"Simons","year":"1996","journal-title":"Med J Aust"},{"issue":"3","key":"10.4065\/83.7.758_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1378\/chest.120.3.979","article-title":"Lipid disorders: justification of methods and goals of treatment","volume":"120","author":"Braunstein","year":"2001","journal-title":"Chest"},{"issue":"20","key":"10.4065\/83.7.758_bib6","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1001\/archinte.158.20.2179","article-title":"\u201cConventional\u201d and \u201cunconventional\u201d medicine: can they be integrated [editorial]?","volume":"158","author":"Dalen","year":"1998","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.4065\/83.7.758_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7326\/0003-4819-135-4-200108210-00011","article-title":"Long-term trends in the use of complementary and alternative medical therapies in the United States","volume":"135","author":"Kessler","year":"2001","journal-title":"Ann Intern Med"},{"issue":"19","key":"10.4065\/83.7.758_bib8","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","year":"2001","journal-title":"JAMA"},{"key":"10.4065\/83.7.758_bib9","first-page":"1","article-title":"Complementary and alternative medicine use among adults: United States, 2002","volume":"343","author":"Barnes","year":"2004","journal-title":"Adv Data"},{"issue":"19","key":"10.4065\/83.7.758_bib10","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.295.19.2262","article-title":"Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial","volume":"295","author":"Berthold","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.4065\/83.7.758_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/acm.2006.6206","article-title":"Dietary supplements for the prevention and treatment of coronary artery disease","volume":"13","author":"Knox","year":"2007","journal-title":"J Altern Complement Med"},{"issue":"6","key":"10.4065\/83.7.758_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.290.6.765","article-title":"Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial","volume":"290","author":"Szapary","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.4065\/83.7.758_bib13","first-page":"269","article-title":"Eggplant (Solanum melongena) extract does not alter serum lipid levels","volume":"82","author":"Praca","year":"2004","journal-title":"Arq Bras Cardiol"},{"issue":"4","key":"10.4065\/83.7.758_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1592\/phco.21.5.481.34499","article-title":"Evaluation of the antihyperlipidemic properties of dietary supplements","volume":"21","author":"Caron","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.4065\/83.7.758_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ctim.2005.08.003","article-title":"Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration","volume":"13","author":"Ulbricht","year":"2005","journal-title":"Complement Ther Med"},{"issue":"7","key":"10.4065\/83.7.758_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0002-9149(94)90307-7","article-title":"Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up","volume":"74","author":"Bradford","year":"1994","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.4065\/83.7.758_bib17","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.4065\/83.7.758_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4065\/83.3.324","article-title":"Omega-3 fatty acids for cardioprotection","volume":"83","author":"Lee","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"22","key":"10.4065\/83.7.758_bib19","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.295.22.2613","article-title":"Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial","volume":"295","author":"Brouwer","year":"2006","journal-title":"JAMA"},{"issue":"6A","key":"10.4065\/83.7.758_bib20","doi-asserted-by":"crossref","first-page":"35C","DOI":"10.1016\/j.amjcard.2006.11.020","article-title":"Safety considerations with omega-3 fatty acid therapy","volume":"99","author":"Bays","year":"2007","journal-title":"Am J Cardiol"},{"issue":"6A","key":"10.4065\/83.7.758_bib21","doi-asserted-by":"crossref","first-page":"44C","DOI":"10.1016\/j.amjcard.2006.11.021","article-title":"Expert opinion: omega-3 fatty acids and bleeding\u2014cause for concern?","volume":"99","author":"Harris","year":"2007","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.4065\/83.7.758_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.mol.0000236363.63840.16","article-title":"Why do omega-3 fatty acids lower serum triglycerides?","volume":"17","author":"Harris","year":"2006","journal-title":"Curr Opin Lipidol"},{"issue":"18","key":"10.4065\/83.7.758_bib23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.4065\/83.7.758_bib24","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.38415.644155.8F","article-title":"Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study","volume":"330","author":"Trichopoulou","year":"2005","journal-title":"BMJ"},{"issue":"6","key":"10.4065\/83.7.758_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study","volume":"99","author":"de Lorgeril","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.4065\/83.7.758_bib26","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.CIR.103.1.e1","article-title":"Exercise training in coronary artery disease and coronary vasomotion","volume":"103","author":"Gielen","year":"2001","journal-title":"Circulation"},{"issue":"7","key":"10.4065\/83.7.758_bib27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0895-7061(99)00047-3","article-title":"A weight reduction and weight maintenance program with long-lasting improvement in left ventricular mass and blood pressure","volume":"12","author":"Himeno","year":"1999","journal-title":"Am J Hypertens"},{"issue":"4","key":"10.4065\/83.7.758_bib28","first-page":"262","article-title":"Short-term effects of two integrated, non-pharmacological body weight reduction programs on coronary heart disease risk factors in young obese patients","volume":"16","author":"Sartorio","year":"2003","journal-title":"Diabetes Nutr Metab"},{"issue":"6","key":"10.4065\/83.7.758_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1524-6175.2007.06625.x","article-title":"Statins and blood pressure: is there an effect or not?","volume":"9","author":"Sarafidis","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"188","key":"10.4065\/83.7.758_bib30","first-page":"463","article-title":"Myoglobinuria, rhabdomyolysis and marathon running","volume":"47","author":"Schiff","year":"1978","journal-title":"Q J Med"},{"issue":"12","key":"10.4065\/83.7.758_bib31","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0026-0495(91)90039-Y","article-title":"Effects of exercise and lovastatin on serum creatine kinase activity","volume":"40","author":"Thompson","year":"1991","journal-title":"Metabolism"},{"issue":"10","key":"10.4065\/83.7.758_bib32","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0026-0495(97)90218-3","article-title":"Lovastatin increases exercise-induced skeletal muscle injury","volume":"46","author":"Thompson","year":"1997","journal-title":"Metabolism"},{"issue":"5","key":"10.4065\/83.7.758_bib33","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/ajcn\/82.5.957","article-title":"Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol","volume":"82","author":"Lefevre","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.4065\/83.7.758_bib34","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/ajcn\/70.6.992","article-title":"HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects","volume":"70","author":"Berglund","year":"1999","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.4065\/83.7.758_bib35","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.amjcard.2006.05.024","article-title":"A population-based, cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic disease","volume":"98","author":"Hsia","year":"2006","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.4065\/83.7.758_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjcard.2007.01.071","article-title":"Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study)","volume":"100","author":"Frontini","year":"2007","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.4065\/83.7.758_bib37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/euhj.2000.2408","article-title":"Importance of HDL cholesterol levels and the total\/HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia","volume":"22","author":"Real","year":"2001","journal-title":"Eur Heart J"},{"issue":"15","key":"10.4065\/83.7.758_bib38","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM200304103481515","article-title":"Effects of exercise on plasma lipoproteins [letter]","volume":"348","author":"Schmidt-Trucks\u00e4ss","year":"2003","journal-title":"N Engl J Med"},{"issue":"19","key":"10.4065\/83.7.758_bib39","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMoa020194","article-title":"Effects of the amount and intensity of exercise on plasma lipoproteins","volume":"347","author":"Kraus","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.4065\/83.7.758_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.293.1.43","article-title":"Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial","volume":"293","author":"Dansinger","year":"2005","journal-title":"JAMA"},{"key":"10.4065\/83.7.758_bib41","author":"Moore"},{"issue":"2","key":"10.4065\/83.7.758_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/107555301750164181","article-title":"An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents","volume":"7","author":"Heber","year":"2001","journal-title":"J Altern Complement Med"},{"issue":"5","key":"10.4065\/83.7.758_bib43","first-page":"611","article-title":"Are pleiotropic effects of statins real?","volume":"3","author":"Corsini","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"10.4065\/83.7.758_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1368-504X.2004.00391.x","article-title":"Cardioprotective and other emerging effects of statins","volume":"143","author":"Davignon","year":"2004","journal-title":"Int J Clin Pract Suppl"},{"issue":"14","key":"10.4065\/83.7.758_bib45","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611609142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611609142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T14:09:02Z","timestamp":1558102142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611609142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0025619611609142"],"URL":"https:\/\/doi.org\/10.4065\/83.7.758","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}